SlideShare uma empresa Scribd logo

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn

•Transferir como PPT, PDF•
•
PeerVoice
PeerVoice

Asma Khalil, MBBCh, MD(Res), FRCOG, MSc(Epi), and Enrico Lopriore, MD, PhD, discuss haemolytic disease of the fetus and newborn in this CE activity titled "When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn." For the full presentation, please visit us at www.peervoice.com/BKD870.

Saúde e medicina
1 de 38
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn

Recomendados

Case Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AMLCase Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AML
PeerVoice
 
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 

Recomendados

Case Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AMLCase Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AML
PeerVoice
 
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
PeerVoice
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
PeerVoice
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
PeerVoice
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
PeerVoice
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
PeerVoice
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
PeerVoice
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
PeerVoice
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
PeerVoice
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
PeerVoice
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
PeerVoice
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
PeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
PeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
PeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
PeerVoice
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
PeerVoice
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
Sherrylee83
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Catherine Liao
 

Mais conteúdo relacionado

Mais de PeerVoice

Mais de PeerVoice (20)

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
 

Último

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
Golden Helix
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
healthwatchghana
 

Último (20)

5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx